Multiple Myeloma News, Features & Updates
FDA Approves Zenbexus Combination for Multiple Myeloma
- FDA Approves Sarclisa Escena, an Under-the-Skin Injection for Multiple Myeloma
July 13, 2026 — The FDA has approved Sarclisa Escena (isatuximab-irfc) for use in combination with other cancer treatments in adults with multiple myeloma.
- New Treatment for Multiple Myeloma: An Expert’s Insights and Key Facts
A new treatment option for multiple myeloma provides new hope. See what a cancer doctor has to say about how it works and what to expect.
- From Lab to Pharmacy: The Journey to FDA Approval for a Multiple Myeloma Drug
So there’s a new drug for treating multiple myeloma. Just how did it get studied and approved? Find out here.
- Tecvayli Plus Darzalex Faspro: FDA Approves Under‑the‑Skin Combo Immune Therapy as a New Second-Line Option for Multiple Myeloma
March 6, 2026 — The FDA has approved Tec-Dara – a combination of the drugs Tecvayli (teclistamab) and Darzalex Faspro (daratumumab and hyaluronidase) – to treat multiple myeloma in adults whose cancer has come back or did not respond to previous treatment.
- FDA Approves Darzalex Faspro as Part of a New First-Line Quadruplet Regimen for Multiple Myeloma
January 29, 2026 — The FDA has approved Darzalex Faspro for use in combination with bortezomib, lenalidomide, and dexamethasone (the D-VRd regimen), for adults with newly diagnosed multiple myeloma who are unable to receive a stem cell transplant.
- Talking to Your Care Team About Switching RRMM Treatment
Know how to talk to your care team about treatment options and decision steps, and learn what to ask.
- Hope on the Horizon: Ongoing Research in Refractory Multiple Myeloma
There’s no cure for multiple myeloma, but there are more treatments now than ever before. Learn about the most recent scientific breakthroughs.
- My Diagnosis Story: Refractory Multiple Myeloma
One woman living with refractory multiple myeloma shares her diagnosis story and advice for others facing a similar journey.
- Expert Q&A: A Doctor's Experience With Refractory Multiple Myeloma
What happens when multiple myeloma doesn’t respond to treatment? And why can this happen? An oncologist has answers.
- Advances in Multiple Myeloma Treatment
Emerging therapies are expanding the possibilities for longer remissions and hope for a cure in patients with multiple myeloma – a disease that was once considered incurable.
- Expert Q&A: Multiple Myeloma
A multiple myeloma expert gives a firsthand perspective on this type of blood cancer, answering your questions about disease basics, treatment, and how you can be an active part of your care.
- Darzalex Faspro: A New Treatment for High-Risk Smoldering Multiple Myeloma
November 7, 2025 — Darzalex Faspro is a medicine used to treat adults with multiple myeloma, a type of blood cancer, and amyloidosis, a rare condition where abnormal proteins build up in organs.
- Blenrep Combination Therapy Approved by FDA for Relapsed or Refractory Multiple Myeloma
October 27, 2025 — The FDA OKs the combination of Blenrep plus two other medicines – bortezomib and dexamethasone – to treat adults with multiple myeloma that has come back or stopped responding to treatment.
- Life With a Rare Condition: Living With Multiple Myeloma
Patients talk to WebMD about their lives during and after treatment for multiple myeloma, or bone marrow cancer.
- FDA Greenlights New Treatment for Advanced Blood Cancer
July 3, 2025 — A new treatment has received a quick federal nod for a common blood cancer, which could affect more than 36,000 people and result in around 12,000 deaths in the U.S. this year alone.
- CAR T-Cell Therapy: Disparities in Treatment
Access to this treatment is limited in people of color, especially African Americans. Researchers explore why.
- Caring for Someone With RRMM
Learn more about relapsed/refractory multiple myeloma (RRMM) and how you can offer the best support possible for a loved one with RRMM.
- Racial and Ethnic Disparities in RRMM
Learn more about how racial and ethnic disparities affect relapsed/refractory multiple myeloma (RRMM) outcomes.
- Newest Treatments for RRMM
The latest advances in treatments for relapsed/refractory multiple myeloma (RRMM) include medicines that better target myeloma cells. Learn more.
- Multiple Myeloma: How Do Disparities Affect Outcomes?
Learn how race can affect the treatment and diagnosis of this blood cancer and what that means for people who have it.
- Boosting Minority Enrollment in Clinical Trials
Learn why these disparities exist and what’s necessary to improve them.
- The Science Behind Multiple Myeloma Disparities
Multiple myeloma impacts Black people at twice the rate of white people and at a younger age. What are the scientific reasons for these differences?
- Multiple Myeloma in Black and Hispanic Communities
These groups face unequal outcomes. Here are some reasons why and a way to bring about change.
- Multiple Myeloma and Your Relationships
WebMD explores how multiple myeloma affects your relationships with family, friends, and significant others.
- Things People With Multiple Myeloma Wish You Knew
Multiple myeloma can take a toll on your life, but better treatments are bringing hope. And a diagnosis doesn’t mean you have to put your life on hold.
- Multiple Myeloma: What to Know When Newly Diagnosed
When you get a diagnosis of multiple myeloma, you may not even know what it is. Find out why this type of cancer is different from most others and what your treatment options look like.
- Multiple Myeloma: Getting the Support You Need
People who have multiple myeloma often need emotional and psychological support. You can get this from social workers, psychologists, support groups, and peer counselors.
- What’s New in Multiple Myeloma Treatment
Treatments for this blood cancer have grown a great deal. Newer drugs help people live longer and enjoy a better quality of life.
- How to Choose the Right Multiple Myeloma Treatment
Diagnosed with multiple myeloma? How to decide which treatment is best for you.
- Side Effects of Multiple Myeloma Treatment
Diagnosed with multiple myeloma? Check out these proven strategies for conquering the treatment-related side effects.
- Singer Diana Krall Fundraises for Leukemia
Diana Krall heads up a star-studded charity event aimed at raising money for leukemia research.
